Keeling; Suzanne Elaine
Patent Applications and Registrations
Patent applications and USPTO patent grants for Keeling; Suzanne Elaine.The latest application filed is for "novel compounds".
Company Profile
6.30.36
- Keeling; Suzanne Elaine - Stevenage GB
- Keeling; Suzanne Elaine - Hertfordshire GB
Patent Activity
| Patent | Date |
|---|---|
| Compounds Grant 10,946,025 - Hamblin , et al. March 16, 2 | 2021-03-16 |
| Novel Compounds App 20200206237 - HAMBLIN; Julie Nicole ; et al. | 2020-07-02 |
| Compounds Grant 10,624,898 - Hamblin , et al. | 2020-04-21 |
| Novel Compounds App 20190328744 - HAMBLIN; Julie Nicole ; et al. | 2019-10-31 |
| Compounds Grant 10,383,879 - Hamblin , et al. A | 2019-08-20 |
| Novel Compounds App 20190175608 - HAMBLIN; Julie Nicole ; et al. | 2019-06-13 |
| Novel Compounds App 20180325911 - HAMBLIN; Julie Nicole ; et al. | 2018-11-15 |
| Novel Compounds App 20170157136 - HAMBLIN; Julie Nicole ; et al. | 2017-06-08 |
| Novel Compounds App 20170015656 - HAMBLIN; Julie Nicole ; et al. | 2017-01-19 |
| Novel Polymorphs and Salts App 20160237073 - HAMBLIN; Julie Nicole ; et al. | 2016-08-18 |
| Polymorphs and salts Grant 9,353,098 - Hamblin , et al. May 31, 2 | 2016-05-31 |
| Indazole derivatives for use in the treatment of influenza virus infection Grant 9,326,987 - Hamblin , et al. May 3, 2 | 2016-05-03 |
| Novel Compounds App 20150328226 - HAMBLIN; Julie Nicole ; et al. | 2015-11-19 |
| Novel Polymorphs and Salts App 20150299177 - HAMBLIN; Julie Nicole ; et al. | 2015-10-22 |
| Polymorphs and salts Grant 9,102,668 - Hamblin , et al. August 11, 2 | 2015-08-11 |
| 6-(1H-indol-4-yl)-4-(5-{[4-1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol- -2-yl)-1H-indazole hemi succinate salt, polymorphs and pharmaceutical compositions thereof Grant 8,993,576 - Hamblin , et al. March 31, 2 | 2015-03-31 |
| Novel Polymorphs and Salts App 20140256721 - Hamblin; Julie Nicole ; et al. | 2014-09-11 |
| Polymorphs and salts Grant 8,735,390 - Hamblin , et al. May 27, 2 | 2014-05-27 |
| Novel Compounds App 20140080830 - Hamblin; Julie Nicole ; et al. | 2014-03-20 |
| Compounds Grant 8,609,657 - Hamblin , et al. December 17, 2 | 2013-12-17 |
| Compounds Grant 8,586,590 - Hamblin , et al. November 19, 2 | 2013-11-19 |
| Compounds Grant 8,586,583 - Hamblin , et al. November 19, 2 | 2013-11-19 |
| Compounds Grant 8,580,797 - Hamblin , et al. November 12, 2 | 2013-11-12 |
| Compounds Grant 8,575,162 - Hamblin , et al. November 5, 2 | 2013-11-05 |
| 4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases Grant 8,524,751 - Hamblin , et al. September 3, 2 | 2013-09-03 |
| Polymorphs and Salts App 20130203772 - Hamblin; Julie Nicole ; et al. | 2013-08-08 |
| Novel Use App 20130165433 - Baldwin; Ian Robert ; et al. | 2013-06-27 |
| Novel Polymorphs and Salts App 20130165441 - Hamblin; Julie Nicole ; et al. | 2013-06-27 |
| Novel Compounds App 20130131080 - HAMBLIN; Julie Nicole ; et al. | 2013-05-23 |
| Novel Compounds App 20130096117 - HAMBLIN; Julie Nicole ; et al. | 2013-04-18 |
| Novel Compounds App 20130029985 - HAMBLIN; Julie Nicole ; et al. | 2013-01-31 |
| 4-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases App 20120053166 - Hamblin; Julie Nicole ; et al. | 2012-03-01 |
| Novel Compounds App 20120046286 - Hamblin; Julie Nicole ; et al. | 2012-02-23 |
| Novel Compounds App 20100280045 - HAMBLIN; Julie Nicole ; et al. | 2010-11-04 |
| Novel Compounds App 20100280029 - HAMBLIN; Julie Nicole ; et al. | 2010-11-04 |
| Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases Grant 7,622,464 - Ancliff , et al. November 24, 2 | 2009-11-24 |
| Morpholin-acetamide Derivatives For The Treatment Of Inflammatory Diseases App 20090163495 - Ancliff; Rachael Anne ; et al. | 2009-06-25 |
| Pyrazolo[3,4-b]pyridine compounds, and their use as a PDE4 inhibitors App 20090131431 - Edlin; Christopher David ; et al. | 2009-05-21 |
| Pyrazolo[3,4-B]Pyridine Compound, and Its Use as a Pde4 Inhibitor App 20080255186 - Christensen; Siegfried Benjamin ; et al. | 2008-10-16 |
| Compounds useful in the treatment of inflammatory diseases Grant 7,157,457 - Ancliff , et al. January 2, 2 | 2007-01-02 |
| Morpholin-acetamide derivatives for the treatment of inflammatory diseases Grant 7,101,882 - Ancliff , et al. September 5, 2 | 2006-09-05 |
| Morpholin-acetamide derivatives for the treatment of inflammatory diseases App 20060079525 - Ancliff; Rachael Anne ; et al. | 2006-04-13 |
| Novel compounds App 20060063765 - Ancliff; Rachael Ann ; et al. | 2006-03-23 |
| N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions App 20060058299 - Ancliff; Rachael Ann ; et al. | 2006-03-16 |
| Compounds useful in the treatment of inflammatory diseases App 20040058907 - Ancliff, Rachael Anne ; et al. | 2004-03-25 |
| Morpholin-acetamide derivatives for the treatment of inflammatory diseases App 20040058923 - Ancliff, Rachael Anne ; et al. | 2004-03-25 |
| 2-(purin-9-yl)-Tetrahydrofuran-3,4-diol derivatives Grant 6,534,486 - Allen , et al. March 18, 2 | 2003-03-18 |
| 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives Grant 6,528,494 - Cox , et al. March 4, 2 | 2003-03-04 |
| 2-(Purin -9-yl)-tetrahydrofuran-3,4-diol derivatives Grant 6,495,528 - Allen , et al. December 17, 2 | 2002-12-17 |
| 2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives Grant 6,426,337 - Cox , et al. July 30, 2 | 2002-07-30 |
| 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives App 20020086850 - Cox, Brian ; et al. | 2002-07-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 